Picker sees MRI's future in Outlook

Article

Picker International is tossingits hat into the interventional MRI ring with Outlook, a new scannerto be shown as a work-in-progress at the RSNA meeting. The Clevelandvendor plans to market the system as a fully functional whole-bodyscanner that also

Picker International is tossingits hat into the interventional MRI ring with Outlook, a new scannerto be shown as a work-in-progress at the RSNA meeting. The Clevelandvendor plans to market the system as a fully functional whole-bodyscanner that also enables clinicians to explore the future ofinterventional MRI.

Outlook features an open-access C-shaped magnet, a design alsoused by Siemens' Magnetom Open scanner (SCAN 4/6/94). Outlookdiffers from Open in a number of important ways, however, accordingto manager of business development Richard Hullihen.

Outlook uses iron-core resistive magnet technology with a fieldstrength that is 20% higher than the 0.2-tesla Open, Hullihentold SCAN. This translates into either improved signal-to-noiseratio or faster scanning time. Outlook also has a patient gapthat is 20% larger than that of Open, allowing easier physicianaccess to patients, he said. The system weighs 12 tons and canbe ramped to field in 10 minutes.

To achieve a more stable magnetic field for Outlook, Pickerdeveloped a technology it calls electron spin resonance (ESR)field lock. ESR is the product of Picker's research in low-fieldOverhauser MRI techniques (SCAN 2/13/93).

Picker plans to market the system as a fully functional whole-bodyscanner that can be purchased for under $1 million. The systemcan also serve as a platform for advanced interventional MRI techniques,which Picker expects to become a growing niche, especially asimaging facilities look for ways to differentiate themselves whencompeting for patient referrals.

Picker is working on integrating Outlook with ViewPoint, thevendor's new image-guided surgery workstation (SCAN 11/9/94),as well as magnetic source imaging (MSI) devices such as Picker'sNeuromag-122. Picker intends to develop the capability for real-timefunctional imaging for surgical planning by integrating interventionalMRI and MSI data, according to Picker vice president Surya Mohapatra.

Picker expects to have a 510(k) application on file with theFood and Drug Administration for Outlook before the RSNA meeting.

Picker will also display its prowess in miniPACS by unveilingGalaxy, a work-in-progress multimodality image management anddistribution system. Galaxy will link Picker scanners and thoseof other vendors in a scalable DICOM 3.0-compatible network, Mohapatrasaid.

A key part of Galaxy is Montage, a new image viewing workstationdesigned to be a digital light box for clinicians. Montage runson a DEC Alpha platform and is available with two to six monitors.Montage can be networked with Picker's modality-specific imageprocessing workstations, including Voxel Q, ViStar XL and OdysseyVP.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.